Øystein Rekdal
Vorstandsvorsitzender bei LYTIX BIOPHARMA
Profil
Øystein Rekdal is the founder of Lytix Biopharma AS, a company founded in 2003.
He holds the title of Chief Executive Officer at Lytix Biopharma AS starting in 2019.
Dr. Rekdal's current job is as a Professor at the University of Tromso.
He previously worked as a Director at Prophylix AS.
Dr. Rekdal obtained a doctorate degree from the University of Tromso.
Aktive Positionen von Øystein Rekdal
| Unternehmen | Position | Beginn |
|---|---|---|
| LYTIX BIOPHARMA | Vorstandsvorsitzender | 11.09.2019 |
| University of Tromso | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Øystein Rekdal
| Unternehmen | Position | Ende |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Direktor/Vorstandsmitglied | - |
Ausbildung von Øystein Rekdal
| University of Tromso | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
